Canada markets closed

Cullinan Therapeutics, Inc. (CGEM)

NasdaqGS - NasdaqGS Real Time Price. Currency in USD
Add to watchlist
17.43-0.08 (-0.46%)
At close: 04:00PM EDT
17.43 0.00 (0.00%)
After hours: 04:57PM EDT
Show:
Income Statement
Cash Flow
Annual

Balance Sheet

All numbers in thousands
Breakdown
2023-12-31
2022-12-31
2021-12-31
2020-12-31
Assets
Current Assets
Cash
Cash And Cash Equivalents
98,434
156,152
59,774
168,198
Other Short Term Investments
368,633
311,140
230,692
42,008
Total Cash
467,067
467,292
290,466
210,206
Other Current Assets
13,124
7,180
6,098
2,072
Total Current Assets
480,191
474,472
296,564
212,278
Non-current assets
Property, plant and equipment
Gross property, plant and equipment
3,884
5,439
309
309
Accumulated Depreciation
-352
-135
-232
-179
Net property, plant and equipment
3,532
5,304
77
130
Equity and other investments
0
80,882
140,397
0
Other long-term assets
459
459
147
2,300
Total non-current assets
3,991
86,645
140,621
2,430
Total Assets
484,182
561,117
437,185
214,708
Liabilities and stockholders' equity
Liabilities
Current Liabilities
Current Debt
-
178
-
-
Accounts Payable
2,493
2,660
3,169
9,679
Taxes payable
0
4,282
0
-
Accrued liabilities
8,434
7,486
5,028
2,878
Other Current Liabilities
914
1,955
973
-
Total Current Liabilities
28,137
22,498
11,746
14,320
Non-current liabilities
Total non-current liabilities
2,150
3,590
65
74
Total Liabilities
30,287
26,088
11,811
14,394
Stockholders' Equity
Common Stock
4
5
4
3
Retained Earnings
-200,857
-47,695
-158,909
-93,339
Accumulated other comprehensive income
-129
-2,601
-838
-2
Total stockholders' equity
453,703
535,029
424,971
199,010
Total liabilities and stockholders' equity
484,182
561,117
437,185
214,708